Skip to main content
Friday
November 08, 2024
Sign In
Subscribe
Home
Epaper
Economy
Aviation
Banking
Bazaar
Budget
Industry
NBR
RMG
Corporates
Stocks
Analysis
Videos
Podcast
World+Biz
Features
Book Review
Brands
Earth
Explorer
Food
Habitat
In Focus
Luxury
Mode
Panorama
Pursuit
Wheels
Subscribe
Epaper
GOVT. Ad
More
Sports
TBS Graduates
Thoughts
Splash
Bangladesh
Supplement
Infograph
Archive
Gallery
Long Read
Interviews
Offbeat
Tech
Magazine
Climate Change
Health
Cartoons
বাংলা
FRIDAY,
NOVEMBER 08, 2024
Serum Institute of India (SII)
South Asia
India develops its first cervical cancer vaccine
Global Economy
Indian vaccine giant Serum plans African plant in global expansion
Coronavirus chronicle
Omicron-specific booster shot possible: SII CEO Adar Poonawalla
Coronavirus chronicle
Serum Institute to resume supply of Covishield to Covax: Reports
South Asia
India rules out reducing gap between Covishield doses
Coronavirus chronicle
India allows Serum Institute to enrol 7-11 year olds in Novavax Covid-19 vaccine trial
Coronavirus chronicle
India's Serum Institute to invest $68 million in UK vaccine maker Oxford Biomedica
Covid-19 in Bangladesh
Bangladesh to get vaccines from India soon: Doraiswami
Bangladesh
SII must return money if they fail to deliver vaccines: Health minister
World+Biz
Serum Institute of India to manufacture Sputnik V starting September
Coronavirus chronicle
India raises Covid vaccine production amid sharp dip in cases
Coronavirus chronicle
SII seeks EU travel approval for its Covishield vaccine
Coronavirus chronicle
SII to introduce Novavax vaccine in India by September
Show More